	US 12,268,796 B2
	System and methods for soft-tissue augmentation
Alan G. Taylor, Memphis, TN (US); Bruce R. Lawrence, Oceanside, CA (US); and Rebecca Hawkins Wahl, Escondido, CA (US)
Assigned to TheraMicro, LLC, Memphis, TN (US)
Filed by NuVista, LLC, Carlsbad, CA (US)
Filed on Feb. 2, 2021, as Appl. No. 17/165,371.
Application 17/165,371 is a continuation in part of application No. 15/987,732, filed on May 23, 2018, granted, now 12,133,930.
Claims priority of provisional application 62/510,601, filed on May 24, 2017.
Prior Publication US 2021/0154367 A1, May 27, 2021
Int. Cl. A61L 27/36 (2006.01); A61L 27/12 (2006.01); A61L 27/38 (2006.01); A61L 27/50 (2006.01); A61M 5/46 (2006.01)

CPC A61L 27/3608 (2013.01) [A61L 27/12 (2013.01); A61L 27/3839 (2013.01); A61L 27/50 (2013.01); A61M 5/46 (2013.01); A61L 2430/34 (2013.01)]

11 Claims

1. A soft-tissue augmenting kit comprising:

an injectable composition for augmenting one or more soft tissues of a human or an animal, comprising:

a soft-tissue augmenting agent; and

a vehicle for the soft-tissue augmenting agent; and

a targeting arm that snaps onto a barrel of a syringe, the targeting arm comprising a longitudinal member that is parallel to and extending in a same direction as the needle when the targeting arm and the needle are both coupled to the syringe; and

wherein the longitudinal member comprising a fixed length in the targeting arm to control an injection depth for an injection of the injectable composition with the syringe.